Ocular Therapeutix saw the highest growth of 1.49% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.49% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Ocular Therapeutix’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Ocular Therapeutix has been focused on protecting inventions in Australia(AU) with three publications in Q2 2024
The Australia(AU) Patent Office dominates the patent filings and grants with nearly 33% filings and 100% grants. The Australia(AU), United States(US), European Patent Office(EPO), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where Ocular Therapeutix is filings its patents. Among the top granted patent authorities, Ocular Therapeutix has 100% of its grants in Australia(AU).
AbbVie and Roche could be the strongest competitors for Ocular Therapeutix
In terms of grant share, Ocular Therapeutix stands in third position among its competitors. AbbVie and Roche secured the top positions according to recent patent publication data.
Patents related to cell & gene therapy lead Ocular Therapeutix's portfolio
Ocular Therapeutix has the highest number of patents in cell & gene therapy. For cell & gene therapy, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Ophthalmic devices related patents lead Ocular Therapeutix portfolio followed by petrochemicals, and viral conjunctivitis
Ocular Therapeutix has highest number of patents in ophthalmic devices followed by petrochemicals, viral conjunctivitis, glaucoma, and open-angle glaucoma.
For comprehensive analysis of Ocular Therapeutix's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
